Home > Boards > US Listed > Medical - Drugs > Viracta Therapeutics Inc (VIRX)

Not even on anyone's radar. 16.25-18. rough 10%

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Jconwon Member Profile
 
Followed By 0
Posts 26
Boards Moderated 0
Alias Born 02/13/21
160x600 placeholder
Viracta Up 5% After It Reacquires Rights to Combination Therapy in China Dow Jones News - 8/23/2021 11:15:00 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 8/17/2021 6:12:09 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 8/17/2021 6:11:09 PM
Initial Statement of Beneficial Ownership (3) Edgar (US Regulatory) - 8/17/2021 6:04:32 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 8/16/2021 4:47:22 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 8/12/2021 4:08:28 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 7/21/2021 8:17:01 AM
Viracta Therapeutics gets FDA clearance for early stage carcinoma study Seeking Alpha - 7/21/2021 8:15:50 AM
Viracta Therapeutics joins Russell 2000, 3000, Microcap indexes Seeking Alpha - 6/28/2021 9:34:45 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/1/2021 5:49:52 PM
Viracta Therapeutics files for $200M mixed shelf offering Seeking Alpha - 5/28/2021 5:28:22 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 5/28/2021 5:02:14 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 5/13/2021 5:46:29 PM
Quarterly Report (10-q) Edgar (US Regulatory) - 5/13/2021 7:08:14 AM
Viracta Therapeutics EPS misses by $5.24 Seeking Alpha - 5/12/2021 4:40:07 PM
Analysts Bet on These 2 Biotech Stocks; See Over 50% Upside Potential TipRanks - 4/29/2021 6:01:37 AM
HCA Healthcare downgraded despite strong Q1 results, LHC Group becomes a new catalyst call; and more in today’s analyst act... Seeking Alpha - 4/26/2021 9:00:13 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 4/14/2021 8:01:58 AM
Securities Registration: Employee Benefit Plan (s-8) Edgar (US Regulatory) - 4/2/2021 3:55:02 PM
Xoma is on course for a multi-year high Seeking Alpha - 3/26/2021 2:27:30 PM
AstraZeneca’s updated data to address integrity issue; Vertex moves to focus list at Citi in today’s analyst action Seeking Alpha - 3/25/2021 9:00:10 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 3/23/2021 5:02:40 PM
Amended Current Report Filing (8-k/a) Edgar (US Regulatory) - 3/23/2021 4:07:41 PM
Viracta and XOMA Announce Multi-License Milestone and Royalty Monetization Transaction PR Newswire (US) - 3/23/2021 8:00:00 AM
Amended Statement of Beneficial Ownership (sc 13d/a) Edgar (US Regulatory) - 3/11/2021 6:04:12 AM
Jconwon   Friday, 02/26/21 01:07:44 AM
Re: None
Post # of 12 
Not even on anyone's radar. 16.25-18. rough 10% with almost no volume. Morning trade is good but hard to really predict these things.

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences